TFXTeleflex Incorporated

Globus Medical's debt-free balance sheet, nearly $630M in liquid assets and strong cash flow give it the flexibility to fund growth and support shareholders.

Teleflex Incorporated (NYSE: TFX) (Teleflex) announced today that it priced its private offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2032 (the Notes) at an issue price of 100.000%. The sale of the Notes is expected to close on June 15, 2026, subject to customary...

Teleflex's portfolio reset is pressuring results, but a cheaper valuation and divestiture proceeds could reshape its outlook over the next 6-12 months.

Teleflex Incorporated (NYSE: TFX) (Teleflex) announced today the commencement of a private offering of $500.0 million aggregate principal amount of senior notes due 2032 (the Notes), subject to market and other conditions. The interest rate and other terms of the Notes will be determined at...

Globus Medical is shifting robotics deals to leases and rentals, aiming to expand its installed base and build recurring revenue streams.

TFX targets $2.03B in divestiture proceeds; FTC review, tariffs and remediation costs put 2026 timing, margins and leverage in play.

Globus Medical's Q1 showed margin gains, strong spine and trauma growth, and rising robotics adoption as NuVasive synergies support 2026 targets.

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the Interventional Urology Business Unit has released new clinical data across two major urological congresses, reinforcing the value of the UroLift System and Barrigel rectal spacer in improving...

Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 30, 2026, to shareholders of record at the close of business on May 25, 2026. About Teleflex...